| Breaking News About HRT |
100%
Natural Doctor Formulated I'm confused, which one am I?
60 day money back guarantee
|
![]() ![]() ![]()
|
||||||||||||||||||
| National Heart, Lung,
and Blood Institute Stops Trial of Estrogen Plus Progestin Due to Increased Breast Cancer
Risk, Lack of Overall Benefit As report nationwide on the July 10th, 2002. The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has stopped early a major clinical trial of the risks and benefits of combined estrogen and progestin in healthy menopausal women due to an increased risk of invasive breast cancer. The study had planed to run though 2005. The study included 16,608 women age 50 to 79 its findings for the estrogen plus progestin group compared to placebo include:
The news media acts if this news is brand new. Ann Louis
Gittleman, M.S., C.NS. states in her book "Hormone replace therapy may appear to be
teh easy way out. If it were, believe me, I would be telling you so in the large type. But
synthetic hormone replacement therapy has side effects, some of which are extremely
dangerous. And the longer you stay on any drug therapy, the greater the chance of side
effects" first published in 1998.
|
Home | Products
| Specials
| FAQ | Information
| Contact
Us | Secure Order
|